butorphanol has been researched along with enkephalin, leucine-2-alanine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugorskiĭ, GV; Privalova, IL; Sheveleva, OA; Zav'ialov, AV | 1 |
| Bilibin, DP; Shevelev, OA | 1 |
| Richard, JW; Sanschagrin, D; Thakur, M; Wood, PL | 1 |
| Grebenchikov, OA; Likhvantsev, VV; Moroz, VV; Smirnova, VI; Subbotin, VV | 1 |
4 other study(ies) available for butorphanol and enkephalin, leucine-2-alanine
| Article | Year |
|---|---|
[The characteristics of the opioid regulation of the afferent reactions of the stomach and duodenum to the early stages of their acute damage].
Topics: Afferent Pathways; Animals; Butorphanol; Cats; Cerebral Cortex; Duodenum; Electric Stimulation; Enkephalin, Leucine-2-Alanine; Evoked Potentials; Formaldehyde; Naloxone; Receptors, Opioid; Stomach; Thalamus; Time Factors | 1992 |
[Participation of the opioid-ergic system in the regulation of afferent reactions of the damaged myocardium].
Topics: Animals; Bradykinin; Butorphanol; Cats; Electrocardiography; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Heart; Heart Conduction System; Myocardial Infarction; Naloxone; Neurons, Afferent; Receptors, Opioid | 1988 |
Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesia; Animals; Buprenorphine; Butorphanol; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Male; Rats; Rats, Inbred Strains; Receptors, Opioid; Stereoisomerism; Substrate Specificity | 1983 |
[Intraoperative monitoring of abdominal organs under combined general anesthesia].
Topics: Abdomen; Analgesics, Opioid; Anesthesia, General; Anesthetics; Butorphanol; Enkephalin, Leucine-2-Alanine; Evoked Potentials, Somatosensory; Fentanyl; Humans; Monitoring, Intraoperative; Neuroleptanalgesia; Sympatholytics; Time Factors | 1993 |